Correlation of Parasite Load Determined by Quantitative PCR to Clinical Outcome in a Heart Transplant Patient with Disseminated Toxoplasmosis
- 1 July 2010
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (7) , 2541-2545
Abstract
Disseminated toxoplasmosis is a life-threatening infection in transplant recipients, which results either from reactivation of latent infection or from organ-transmitted primary infection. Preventive measures and diagnostic screening methods differ between countries and are related to the seroprevalence ofToxoplasmaspp. in the general population. Here we report a case of disseminated toxoplasmosis in a heart transplant recipient with previous immunity that occurred after cotrimoxazole prophylaxis for the prevention ofPneumocystis jiroveciipneumonia was stopped. Quantitative PCR proved useful for the diagnosis and monitoring ofToxoplasmainfection. Decreasing parasitic burdens in sequential samples of cerebrospinal fluid, blood, and bronchoalveolar lavage fluid correlated with a favorable outcome and allowed modulation of the immunosuppressive drug regimen. The duration of anti-Toxoplasmatreatment and the need for maintenance prophylaxis are discussed, as well as prophylaxis for solid-organ transplant recipients. Although a rare event in heart transplant recipients,Toxoplasmareactivation must be investigated promptly, since early treatment improves the prognosis.Keywords
This publication has 35 references indexed in Scilit:
- Diagnosis of Toxoplasmosis after Allogeneic Stem Cell Transplantation: Results of DNA Detection and Serological TechniquesClinical Infectious Diseases, 2009
- Transmission of toxoplasmosis in two renal allograft recipients receiving an organ from the same donorTransplant Infectious Disease, 2007
- Is Toxoplasmosis Prophylaxis Necessary in Cardiac Transplantation? Long-term Follow-up at Two Transplant CentersThe Journal of Heart and Lung Transplantation, 2006
- Disseminated toxoplasmosis with pulmonary involvement after heart transplantationTransplant Infectious Disease, 2005
- Trimethoprim‐Sulfamethoxazole as Toxoplasmosis Prophylaxis for Heart Transplant RecipientsClinical Infectious Diseases, 2003
- Effectiveness of Twice-Weekly Pyrimethamine-Sulfadoxine as Primary Prophylaxis of Pneumocystis carinii Pneumonia and Toxoplasmic Encephalitis in Patients with Advanced HIV InfectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Prophylaxis Strategies for Solid‐Organ TransplantationClinical Infectious Diseases, 2001
- Blotting in Toxoplasma-seropositive heartTransplant International, 2000
- Thrice-Weekly Sulfadiazine-Pyrimethamine for Maintenance Therapy of Toxoplasmic Encephalitis in HIV-Infected PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Toxoplasmosis in heart transplant recipientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996